Investment Management Group
1
4M
1
- Stages of investment
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline TNG Pharmaceuticals Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Pharmaceutical.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Yearling Fund II, Texas Halo Fund, Commonwealth Seed Capital.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2014.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Health Care (1)
- Biotechnology (1)
- Pharmaceutical (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| TNG Pharmaceuticals | 06 Feb 2014 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 4M | United States, Kentucky, Louisville |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.